114 related articles for article (PubMed ID: 22891081)
1. High serum estradiol confers no risk for breast cancer: another disparity for sub Saharan Africa women.
Awio JP; Galukande M; Kituuka O; Fualal JO
Pan Afr Med J; 2012; 12():23. PubMed ID: 22891081
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Risk Factors among Ugandan Women at a Tertiary Hospital: A Case-Control Study.
Galukande M; Wabinga H; Mirembe F; Karamagi C; Asea A
Oncology; 2016; 90(6):356-62. PubMed ID: 27104645
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group.
Cauley JA; Lucas FL; Kuller LH; Stone K; Browner W; Cummings SR
Ann Intern Med; 1999 Feb; 130(4 Pt 1):270-7. PubMed ID: 10068384
[TBL] [Abstract][Full Text] [Related]
4. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk.
Dorgan JF; Stanczyk FZ; Kahle LL; Brinton LA
Breast Cancer Res; 2010; 12(6):R98. PubMed ID: 21087481
[TBL] [Abstract][Full Text] [Related]
5. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
6. Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women.
Trabert B; Bauer DC; Buist DSM; Cauley JA; Falk RT; Geczik AM; Gierach GL; Hada M; Hue TF; Lacey JV; LaCroix AZ; Tice JA; Xu X; Dallal CM; Brinton LA
JAMA Netw Open; 2020 Apr; 3(4):e203645. PubMed ID: 32329771
[TBL] [Abstract][Full Text] [Related]
7. Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case-control study in Chongqing, China.
Wang B; Mi M; Wang J; Wei N; Zhang Q; Zhu J; Yang S; Guo B; Xu J; Yang X
Int J Cancer; 2009 Apr; 124(8):1892-9. PubMed ID: 19117053
[TBL] [Abstract][Full Text] [Related]
8. Serum estradiol level and risk of breast cancer during treatment with raloxifene.
Cummings SR; Duong T; Kenyon E; Cauley JA; Whitehead M; Krueger KA;
JAMA; 2002 Jan; 287(2):216-20. PubMed ID: 11779264
[TBL] [Abstract][Full Text] [Related]
9. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer in sub-Saharan African women.
Anim JT
Afr J Med Med Sci; 1993 Mar; 22(1):5-10. PubMed ID: 7839882
[TBL] [Abstract][Full Text] [Related]
11. The serum estradiol concentration is the main determinant of the estradiol concentration in normal breast tissue.
Depypere HT; Bolca S; Bracke M; Delanghe J; Comhaire F; Blondeel P
Maturitas; 2015 May; 81(1):42-5. PubMed ID: 25721699
[TBL] [Abstract][Full Text] [Related]
12. Serum oestradiol and breast cancer risk.
Key TJ
Endocr Relat Cancer; 1999 Jun; 6(2):175-80. PubMed ID: 10731106
[TBL] [Abstract][Full Text] [Related]
13. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.
Cummings SR; Lee JS; Lui LY; Stone K; Ljung BM; Cauleys JA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1047-51. PubMed ID: 15894651
[TBL] [Abstract][Full Text] [Related]
14. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
15. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
[TBL] [Abstract][Full Text] [Related]
17. The evolving epidemic of breast cancer in sub-Saharan Africa: Results from the African Cancer Registry Network.
Joko-Fru WY; Jedy-Agba E; Korir A; Ogunbiyi O; Dzamalala CP; Chokunonga E; Wabinga H; Manraj S; Finesse A; Somdyala N; Liu B; McGale P; Jemal A; Bray F; Parkin DM
Int J Cancer; 2020 Oct; 147(8):2131-2141. PubMed ID: 32306390
[TBL] [Abstract][Full Text] [Related]
18. Serum sex hormone levels in pre- and postmenopausal breast cancer patients.
Ho CC; Rohaizak M; Zulkifli SZ; Siti-Aishah MA; Nor-Aini U; Sharifah-Noor-Akmal SH
Singapore Med J; 2009 May; 50(5):513-8. PubMed ID: 19495523
[TBL] [Abstract][Full Text] [Related]
19. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Nigerian Breast Cancer Study Model for Predicting Individual Breast Cancer Risk in Cameroon and Uganda.
Ashi K; Ndom P; Gakwaya A; Makumbi T; Olopade OI; Huo D
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):98-104. PubMed ID: 36215182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
